Axitinib Inlyta 1mg Tablets are indicated for treatment of renal cell carcinoma for having ability to inhibit tyrosine kinase enzyme. Active compound present in these tablets has molecular formula C22H18N4OS with molar mass of 386.469 g/mol. They show bioavailability of about 58% with protein binding ability of more than 99%. This medicine gets metabolized in liver with help of CYP3A4 & CYP3A5 with elimination half life of 2.5 to 6.1 hours. Axitinib Inlyta 1mg Tablets are available at cost-effective rates in bulk for our respected customers. They show targeted mode of action with excellent effectiveness.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Tablets' You May Like